Daniel Robert Lefebvre, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Orbit | 14 | 2022 | 430 | 3.580 |
Why?
|
| Dacryocystorhinostomy | 7 | 2021 | 71 | 2.060 |
Why?
|
| Orbital Neoplasms | 7 | 2018 | 249 | 1.730 |
Why?
|
| Nasolacrimal Duct | 5 | 2021 | 72 | 1.360 |
Why?
|
| Lacrimal Duct Obstruction | 3 | 2021 | 44 | 1.350 |
Why?
|
| Orbital Diseases | 5 | 2016 | 191 | 1.340 |
Why?
|
| Orbital Fractures | 5 | 2020 | 113 | 1.190 |
Why?
|
| Eyelid Neoplasms | 3 | 2019 | 90 | 1.130 |
Why?
|
| Graves Ophthalmopathy | 5 | 2017 | 94 | 1.050 |
Why?
|
| Diplopia | 4 | 2018 | 177 | 0.950 |
Why?
|
| Exophthalmos | 4 | 2018 | 80 | 0.900 |
Why?
|
| Dacryocystitis | 3 | 2017 | 66 | 0.860 |
Why?
|
| Eye Infections, Parasitic | 2 | 2018 | 22 | 0.850 |
Why?
|
| Mucormycosis | 3 | 2016 | 92 | 0.840 |
Why?
|
| Eye Diseases | 3 | 2022 | 650 | 0.840 |
Why?
|
| Eye Infections, Fungal | 3 | 2016 | 110 | 0.820 |
Why?
|
| Orbital Cellulitis | 3 | 2016 | 34 | 0.800 |
Why?
|
| Eyelids | 4 | 2020 | 245 | 0.780 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 2021 | 241 | 0.740 |
Why?
|
| Eye Injuries, Penetrating | 2 | 2019 | 97 | 0.700 |
Why?
|
| Myiasis | 1 | 2018 | 16 | 0.700 |
Why?
|
| Hemangioma, Cavernous | 1 | 2018 | 110 | 0.680 |
Why?
|
| Diptera | 1 | 2018 | 57 | 0.680 |
Why?
|
| Eye | 1 | 2022 | 718 | 0.670 |
Why?
|
| Mucorales | 2 | 2016 | 28 | 0.650 |
Why?
|
| Cosmetic Techniques | 1 | 2018 | 135 | 0.610 |
Why?
|
| Endoscopy | 9 | 2021 | 1745 | 0.600 |
Why?
|
| Eyelid Diseases | 1 | 2018 | 154 | 0.590 |
Why?
|
| Debridement | 3 | 2016 | 488 | 0.590 |
Why?
|
| Neurothekeoma | 1 | 2014 | 6 | 0.550 |
Why?
|
| Hyaluronic Acid | 1 | 2018 | 505 | 0.540 |
Why?
|
| Ophthalmologic Surgical Procedures | 5 | 2019 | 338 | 0.530 |
Why?
|
| Acrospiroma | 1 | 2014 | 12 | 0.530 |
Why?
|
| Apocrine Glands | 1 | 2014 | 28 | 0.530 |
Why?
|
| Orbital Pseudotumor | 1 | 2014 | 47 | 0.520 |
Why?
|
| Sphenoid Bone | 1 | 2015 | 171 | 0.510 |
Why?
|
| Eccrine Glands | 1 | 2014 | 50 | 0.510 |
Why?
|
| Decompression, Surgical | 5 | 2017 | 593 | 0.510 |
Why?
|
| Immunocompromised Host | 2 | 2016 | 881 | 0.510 |
Why?
|
| Alendronate | 1 | 2014 | 177 | 0.490 |
Why?
|
| Sweat Gland Neoplasms | 1 | 2014 | 104 | 0.470 |
Why?
|
| Eye Infections, Bacterial | 4 | 2016 | 245 | 0.450 |
Why?
|
| Bone Resorption | 1 | 2015 | 747 | 0.430 |
Why?
|
| Orbital Implants | 3 | 2021 | 31 | 0.420 |
Why?
|
| Conjunctiva | 1 | 2014 | 479 | 0.400 |
Why?
|
| Sarcoma | 1 | 2021 | 1856 | 0.380 |
Why?
|
| Collagen | 1 | 2018 | 2693 | 0.380 |
Why?
|
| Diphosphonates | 1 | 2014 | 620 | 0.370 |
Why?
|
| Gloves, Surgical | 1 | 2007 | 26 | 0.340 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2017 | 1272 | 0.330 |
Why?
|
| Needlestick Injuries | 1 | 2007 | 66 | 0.330 |
Why?
|
| Imidazoles | 1 | 2014 | 1279 | 0.330 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2012 | 1173 | 0.310 |
Why?
|
| Bone Density Conservation Agents | 1 | 2014 | 782 | 0.310 |
Why?
|
| Inflammation | 2 | 2022 | 9948 | 0.270 |
Why?
|
| Nasal Mucosa | 2 | 2018 | 368 | 0.270 |
Why?
|
| Disease Management | 1 | 2016 | 2539 | 0.270 |
Why?
|
| Needles | 1 | 2007 | 443 | 0.270 |
Why?
|
| Remission, Spontaneous | 2 | 2015 | 392 | 0.270 |
Why?
|
| Paranasal Sinuses | 2 | 2017 | 268 | 0.260 |
Why?
|
| Immunoenzyme Techniques | 1 | 2007 | 1890 | 0.260 |
Why?
|
| Suture Techniques | 2 | 2014 | 797 | 0.250 |
Why?
|
| Tomography, X-Ray Computed | 10 | 2019 | 20307 | 0.250 |
Why?
|
| Biopsy | 5 | 2019 | 6786 | 0.240 |
Why?
|
| Photography | 2 | 2016 | 535 | 0.230 |
Why?
|
| Transillumination | 1 | 2021 | 21 | 0.220 |
Why?
|
| Oculomotor Muscles | 2 | 2016 | 328 | 0.220 |
Why?
|
| Anophthalmos | 1 | 2021 | 23 | 0.220 |
Why?
|
| Meningitis, Cryptococcal | 1 | 2022 | 61 | 0.220 |
Why?
|
| Entropion | 1 | 2020 | 10 | 0.210 |
Why?
|
| Ectropion | 1 | 2020 | 24 | 0.210 |
Why?
|
| Operating Rooms | 1 | 2007 | 791 | 0.200 |
Why?
|
| Middle Aged | 27 | 2021 | 215428 | 0.200 |
Why?
|
| Surgical Flaps | 3 | 2018 | 1627 | 0.200 |
Why?
|
| Retrospective Studies | 17 | 2021 | 71151 | 0.200 |
Why?
|
| Muir-Torre Syndrome | 1 | 2019 | 11 | 0.200 |
Why?
|
| Humans | 47 | 2022 | 709431 | 0.190 |
Why?
|
| Meibomian Glands | 1 | 2019 | 83 | 0.190 |
Why?
|
| Maxillary Fractures | 1 | 2019 | 21 | 0.190 |
Why?
|
| Zygomatic Fractures | 1 | 2019 | 38 | 0.180 |
Why?
|
| Diagnosis, Differential | 6 | 2018 | 13362 | 0.180 |
Why?
|
| Papilloma | 1 | 2019 | 153 | 0.180 |
Why?
|
| Injections, Intraocular | 1 | 2018 | 30 | 0.180 |
Why?
|
| Hypesthesia | 1 | 2019 | 103 | 0.180 |
Why?
|
| Male | 28 | 2022 | 351848 | 0.180 |
Why?
|
| Frontal Bone | 1 | 2018 | 105 | 0.170 |
Why?
|
| Glucocorticoids | 2 | 2018 | 2109 | 0.160 |
Why?
|
| Nematode Infections | 1 | 2017 | 25 | 0.160 |
Why?
|
| Antifungal Agents | 3 | 2016 | 714 | 0.160 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2018 | 316 | 0.160 |
Why?
|
| Orbit Evisceration | 1 | 2016 | 11 | 0.160 |
Why?
|
| Transplantation, Heterotopic | 2 | 2007 | 181 | 0.160 |
Why?
|
| Biometric Identification | 1 | 2016 | 3 | 0.160 |
Why?
|
| Conjunctival Diseases | 1 | 2017 | 122 | 0.150 |
Why?
|
| Vision Disorders | 2 | 2022 | 1031 | 0.140 |
Why?
|
| Syndrome | 1 | 2022 | 3169 | 0.140 |
Why?
|
| Blinking | 1 | 2016 | 140 | 0.140 |
Why?
|
| Paranasal Sinus Diseases | 1 | 2016 | 130 | 0.140 |
Why?
|
| Skin Neoplasms | 1 | 2014 | 5349 | 0.140 |
Why?
|
| Cerebrospinal Fluid Rhinorrhea | 1 | 2015 | 84 | 0.140 |
Why?
|
| Ophthalmic Artery | 1 | 2015 | 69 | 0.140 |
Why?
|
| Eye Enucleation | 3 | 2021 | 134 | 0.130 |
Why?
|
| Aged | 19 | 2022 | 162592 | 0.130 |
Why?
|
| Female | 25 | 2021 | 377269 | 0.130 |
Why?
|
| Skull Fractures | 1 | 2015 | 211 | 0.130 |
Why?
|
| Panophthalmitis | 1 | 2013 | 6 | 0.130 |
Why?
|
| Prostaglandins, Synthetic | 1 | 2013 | 22 | 0.130 |
Why?
|
| Leiomyosarcoma | 1 | 2017 | 457 | 0.130 |
Why?
|
| Immunohistochemistry | 2 | 2021 | 11904 | 0.120 |
Why?
|
| Aspergillosis | 1 | 2015 | 235 | 0.120 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 1 | 2016 | 254 | 0.120 |
Why?
|
| Skin Abnormalities | 1 | 2013 | 60 | 0.120 |
Why?
|
| Natural Orifice Endoscopic Surgery | 1 | 2015 | 126 | 0.120 |
Why?
|
| Ocular Motility Disorders | 1 | 2014 | 140 | 0.120 |
Why?
|
| Cysts | 1 | 2017 | 628 | 0.110 |
Why?
|
| Pseudomonas Infections | 1 | 2016 | 621 | 0.110 |
Why?
|
| Adult | 17 | 2022 | 212298 | 0.110 |
Why?
|
| Eye Evisceration | 2 | 2021 | 24 | 0.100 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2022 | 1523 | 0.100 |
Why?
|
| Mycoses | 1 | 2014 | 369 | 0.100 |
Why?
|
| Hemangioma | 1 | 2016 | 738 | 0.100 |
Why?
|
| Morbidity | 1 | 2016 | 1694 | 0.100 |
Why?
|
| Visual Acuity | 1 | 2019 | 2494 | 0.100 |
Why?
|
| Face | 1 | 2016 | 965 | 0.100 |
Why?
|
| Accidents, Traffic | 1 | 2015 | 798 | 0.090 |
Why?
|
| Light | 1 | 2016 | 1420 | 0.090 |
Why?
|
| Blindness | 1 | 2013 | 589 | 0.090 |
Why?
|
| Escherichia coli Infections | 1 | 2013 | 551 | 0.090 |
Why?
|
| Postoperative Care | 1 | 2015 | 1513 | 0.090 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2016 | 1268 | 0.090 |
Why?
|
| Uterine Neoplasms | 1 | 2017 | 1473 | 0.090 |
Why?
|
| Horseradish Peroxidase | 1 | 2007 | 188 | 0.080 |
Why?
|
| Cornea | 1 | 2016 | 1449 | 0.080 |
Why?
|
| Antigens, CD | 1 | 2018 | 4201 | 0.080 |
Why?
|
| Reference Values | 1 | 2015 | 5070 | 0.080 |
Why?
|
| Sinusitis | 1 | 2015 | 876 | 0.080 |
Why?
|
| Femoral Vein | 1 | 2007 | 161 | 0.080 |
Why?
|
| Equipment Contamination | 1 | 2007 | 178 | 0.080 |
Why?
|
| Accidents, Occupational | 1 | 2007 | 207 | 0.080 |
Why?
|
| Reconstructive Surgical Procedures | 1 | 2019 | 2151 | 0.070 |
Why?
|
| Software | 2 | 2016 | 4351 | 0.070 |
Why?
|
| Femoral Artery | 2 | 2007 | 950 | 0.070 |
Why?
|
| Glaucoma | 1 | 2013 | 956 | 0.070 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2007 | 258 | 0.070 |
Why?
|
| Aged, 80 and over | 7 | 2019 | 58752 | 0.060 |
Why?
|
| Heart Transplantation | 2 | 2007 | 3073 | 0.060 |
Why?
|
| Recurrence | 1 | 2015 | 8279 | 0.060 |
Why?
|
| Quality Improvement | 1 | 2019 | 3712 | 0.060 |
Why?
|
| Dietary Supplements | 1 | 2015 | 3005 | 0.060 |
Why?
|
| Treatment Outcome | 7 | 2019 | 61963 | 0.060 |
Why?
|
| Young Adult | 4 | 2019 | 56163 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2018 | 34096 | 0.060 |
Why?
|
| Carcinoma | 1 | 2013 | 2330 | 0.050 |
Why?
|
| Cadaver | 2 | 2016 | 1365 | 0.050 |
Why?
|
| Follow-Up Studies | 6 | 2019 | 39394 | 0.050 |
Why?
|
| Neoplasm Proteins | 1 | 2014 | 3884 | 0.050 |
Why?
|
| Adolescent | 3 | 2018 | 85327 | 0.050 |
Why?
|
| Quality of Life | 2 | 2017 | 11553 | 0.050 |
Why?
|
| Oculomotor Nerve | 1 | 2019 | 77 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 10791 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2016 | 8971 | 0.040 |
Why?
|
| Edema | 1 | 2022 | 744 | 0.040 |
Why?
|
| Rats, Inbred ACI | 2 | 2007 | 43 | 0.040 |
Why?
|
| Animals | 5 | 2018 | 170647 | 0.040 |
Why?
|
| Mutation | 1 | 2022 | 29242 | 0.040 |
Why?
|
| Prosthesis Implantation | 1 | 2021 | 663 | 0.040 |
Why?
|
| Aspergillus | 1 | 2015 | 80 | 0.040 |
Why?
|
| Hospitals, Special | 1 | 2016 | 112 | 0.040 |
Why?
|
| Nasal Septum | 1 | 2016 | 134 | 0.030 |
Why?
|
| Rats, Inbred Lew | 2 | 2007 | 1154 | 0.030 |
Why?
|
| Tenotomy | 1 | 2014 | 45 | 0.030 |
Why?
|
| Hyperbaric Oxygenation | 1 | 2015 | 160 | 0.030 |
Why?
|
| Nasal Cavity | 1 | 2016 | 308 | 0.030 |
Why?
|
| Cloprostenol | 1 | 2013 | 22 | 0.030 |
Why?
|
| Baseball | 1 | 2014 | 89 | 0.030 |
Why?
|
| Prostaglandins F, Synthetic | 1 | 2013 | 31 | 0.030 |
Why?
|
| Bacterial Proteins | 1 | 2007 | 4134 | 0.030 |
Why?
|
| Endoscopes | 1 | 2013 | 174 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2017 | 1848 | 0.030 |
Why?
|
| Maxillary Sinus | 1 | 2013 | 176 | 0.030 |
Why?
|
| Blepharoptosis | 1 | 2013 | 138 | 0.030 |
Why?
|
| Ophthalmoplegia | 1 | 2013 | 169 | 0.030 |
Why?
|
| Iatrogenic Disease | 1 | 2014 | 520 | 0.030 |
Why?
|
| Germ-Line Mutation | 1 | 2019 | 1733 | 0.030 |
Why?
|
| Ophthalmology | 1 | 2016 | 478 | 0.020 |
Why?
|
| Amides | 1 | 2013 | 459 | 0.020 |
Why?
|
| Postoperative Complications | 3 | 2021 | 15035 | 0.020 |
Why?
|
| Subcutaneous Fat | 1 | 2013 | 382 | 0.020 |
Why?
|
| Photic Stimulation | 1 | 2016 | 2027 | 0.020 |
Why?
|
| Osteotomy | 1 | 2015 | 801 | 0.020 |
Why?
|
| Otolaryngology | 1 | 2016 | 640 | 0.020 |
Why?
|
| Reoperation | 1 | 2018 | 4155 | 0.020 |
Why?
|
| Prospective Studies | 3 | 2019 | 50734 | 0.020 |
Why?
|
| Echocardiography, Doppler, Pulsed | 1 | 2007 | 78 | 0.020 |
Why?
|
| Pulse | 1 | 2007 | 237 | 0.020 |
Why?
|
| Palpation | 1 | 2007 | 173 | 0.020 |
Why?
|
| Pain | 1 | 2022 | 4623 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2017 | 5168 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2019 | 5913 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2013 | 19798 | 0.020 |
Why?
|
| Carotid Artery, Common | 1 | 2007 | 191 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2019 | 8036 | 0.020 |
Why?
|
| Bacteria | 1 | 2016 | 2055 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 8941 | 0.020 |
Why?
|
| Anastomosis, Surgical | 1 | 2007 | 961 | 0.020 |
Why?
|
| Massachusetts | 1 | 2016 | 8754 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2017 | 6123 | 0.010 |
Why?
|
| Survival Rate | 1 | 2016 | 13363 | 0.010 |
Why?
|
| Age Factors | 1 | 2019 | 18954 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 16161 | 0.010 |
Why?
|
| Rats | 2 | 2007 | 25068 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 12517 | 0.010 |
Why?
|
| Prognosis | 1 | 2019 | 29148 | 0.010 |
Why?
|
| Child | 2 | 2016 | 73998 | 0.010 |
Why?
|
| Pulmonary Artery | 1 | 2007 | 1895 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 19470 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2016 | 7071 | 0.010 |
Why?
|
| Acute Disease | 1 | 2007 | 7201 | 0.010 |
Why?
|
| Heart Rate | 1 | 2007 | 4107 | 0.010 |
Why?
|
| Echocardiography | 1 | 2007 | 5123 | 0.010 |
Why?
|
| Graft Rejection | 1 | 2007 | 4409 | 0.010 |
Why?
|
| Myocardium | 1 | 2007 | 4966 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2013 | 22944 | 0.010 |
Why?
|
| United States | 1 | 2019 | 67177 | 0.010 |
Why?
|
| Risk Factors | 1 | 2015 | 70264 | 0.010 |
Why?
|